Formulary guidance and transparency from P&T to point of care


Reality Check on Dermatology

Market access for dermatology-acne reveals differences in payer coverage across each major channel, as well as specific trends in the drug landscape.  

To help make sense of this new research, MMIT's team of experts has analyzed the data for you and summarized the key findings:

  • Payer Insights: Further escalation of restricted lives across payer pharmacy benefit lives in the commercial and health exchange channels
  • Class Trends: How new market entrants disrupt competitive situations for the major manufacturer players
  • Key Findings: How promotion in this channel serves as a model for other disease areas

What can pharma do to curb this trend and overcome these challenges?

Get the data behind this change and how it could impact your market access plans from MMIT's team.  Their clinical and policy backgrounds provide a unique and expert perspective to help expand your knowledge in the class and guide your decision-making process.

Download the full Reality Check now.